What it is

Cartalax is a Khavinson-school short peptide bioregulator associated with cartilage and connective-tissue research catalogs. These bioregulators are studied as tissue-selective signaling peptides in aging and repair models.

It is sold as a single research compound for laboratory investigation of cartilage-related endpoints. Left Turn Adventures supplies this compound for laboratory and research use only.

Also known as

CTL20 · Cartilage bioregulator · Khavinson short peptide

Proven benefits

Note: Preclinical / literature endpoints for labs — not established human treatment benefits. Not a protocol.

• Cartilage and connective-tissue bioregulator endpoints

• - Chondrocyte and matrix-related markers in preclinical models

• - Joint-tissue aging and repair readouts where studied

• - Short-peptide bioregulator pharmacology (Khavinson class)

• - Comparative connective-tissue research versus other bioregulators

Results timeline

Note: Illustrative research-observation windows — not a clinical schedule. No dosing.

• Week 1–2: Early tissue and inflammation readouts in acute injury or repair models; compound exposure establishing.

• - Week 3–4: Clearer repair, angiogenesis, and mobility-adjacent markers in short research windows.

• - Month 2–3: More pronounced tendon/ligament/soft-tissue endpoints in extended preclinical designs.

• - Month 3–6: Sustained remodeling and recovery-marker observations where studied longer.

The catalog, not a clinic

For laboratory and research use only. Not for human or animal consumption. Products are sold solely to qualified researchers and licensed laboratories. No dosing or reconstitution on this page.